Crossref journal-article
Rockefeller University Press
The Journal of Experimental Medicine (291)
Abstract

The migratory properties of memory T cells provide a model vector system for site-specific delivery of therapeutic transgene factors to autoimmune inflammatory lesions. Lymph node cells from (SWR×SJL)F1 mice immunized with the p139–151 determinant of myelin proteolipid protein (PLP) were transfected with a DNA construct that placed the anti-inflammatory cytokine interleukin-10 (IL-10) cDNA under control of an antigen-inducible IL-2 promoter region. Isolated T cell clones demonstrated antigen-inducible expression of transgene IL-10 and expressed cell surface markers consistent with the phenotype of normal memory T cells. Upon adoptive transfer, transfected T cell clones were able to inhibit onset of experimental autoimmune encephalomyelitis (EAE) and to treat EAE animals therapeutically after onset of neurologic signs. Semiquantitative immunocytochemistry showed a significant correlation between decreased demyelination and treatment with the transfected T cells. Taken together, these data indicate the autoreactive T cells can be genetically designed to produce therapeutic factors in an antigen-inducible manner resulting in a decreased severity of clinical and histological autoimmune demyelinating disease.

Bibliography

Mathisen, P. M., Yu, M., Johnson, J. M., Drazba, J. A., & Tuohy, V. K. (1997). Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells. The Journal of Experimental Medicine, 186(1), 159–164.

Authors 5
  1. Peter M. Mathisen (first)
  2. Min Yu (additional)
  3. Justin M. Johnson (additional)
  4. Judith A. Drazba (additional)
  5. Vincent K. Tuohy (additional)
References 26 Referenced 145
  1. 10.1146/annurev.iy.10.040192.001101 / Annu Rev Immunol / Immunological aspects of demyelinating diseases by Martin (1992)
  2. 10.1016/S0092-8674(00)81107-1 / Cell / Multiple sclerosis: a coordinated immunological attack against myelin the central nervous system by Steinman (1996)
  3. 10.1212/WNL.30.7_Part_2.99 / Neurology / Multiple sclerosis: evidence for immunopathogenesis by Lisak (1980)
  4. 10.1056/NEJM198211043071905 / N Engl J Med / Multiple sclerosis (first of two parts) by McFarlin (1982)
  5. 10.1016/0092-8674(95)90349-6 / Cell / B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: applications to autoimmune disease therapy by Kuchroo (1995)
  6. 10.1084/jem.170.6.2081 / J Exp Med / Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones by Fiorentino (1989)
  7. 10.1126/science.2161559 / Science (Wash DC) / Homology of cytokine synthesis inhibitory factor (IL-10) to Epstein–Barr virus gene BCRFI by Moore (1990)
  8. 10.1073/pnas.88.4.1172 / Proc Natl Acad Sci USA / Isolation and expression of human cytokine synthesis inhibitory factor (CSIF/IL10) cDNA clones: homology to Epstein–Barr virus open reading frame BCRFI by Vieira (1991)
  9. 10.4049/jimmunol.149.7.2496 / J Immunol / Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery by Kennedy (1992)
  10. 10.1002/eji.1830240629 / Eur J Immunol / Interleukin-10 prevents experimental allergic encephalomyelitis in rats by Rott (1994)
  11. 10.1093/nar/18.15.4523 / Nucleic Acids Res / Regulatory anatomy of the murine interleukin-2 gene by Novak (1990)
  12. 10.1007/BF02821509 / Mol Biotech / Polybrene/DMSO-assisted gene transfer by Aubin (1994)
  13. 10.1093/nar/16.5.2352 / Nucleic Acids Res / Transfection of myeloid cell lines using polybrene/DMSO by Chisholm (1988)
  14. 10.1101/gad.1.10.1107 / Genes Dev / Thyroid hormone induction of keratin genes: a two-step activation of gene expression during development by Mathisen (1987)
  15. 10.1021/bi00591a005 / Biochemistry / Isolation of biologically active RNA from sources enriched in ribonucleases by Chirgwin (1979)
  16. {'key': '2023072915173713400_B16', 'first-page': '532', 'article-title': 'A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples', 'volume': '15', 'author': 'Chomczynski', 'year': '1993', 'journal-title': 'BioTechniques'} / BioTechniques / A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples by Chomczynski (1993)
  17. 10.4049/jimmunol.142.5.1523 / J Immunol / Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice by Tuohy (1989)
  18. 10.4049/jimmunol.156.6.2316 / J Immunol / Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival by Qin (1996)
  19. 10.1002/eji.1830261020 / Eur J Immunol / Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13 by Bessis (1996)
  20. 10.1084/jem.179.4.1379 / J Exp Med / Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice by Wogensen (1994)
  21. 10.4049/jimmunol.155.10.5011 / J Immunol / Neuroantigen-specific Th2 cells are inefficient suppressors of experimental autoimmune encephalomyelitis induced effector Th1 cells by Khoruts (1995)
  22. 10.1016/0165-5728(93)90194-4 / J Neuroimmunol / Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10 by van der Veen (1993)
  23. 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-V / J Neurosci Res / IL-10 fails to abrogate experimental autoimmune encephalomyelitis by Cannella (1996)
  24. 10.1084/jem.185.9.1711 / J Exp Med / Local delivery of interleukin-4 by retrovirus-transduced lymphocytes ameliorates experimental autoimmune encephalomyelitis by Shaw (1997)
  25. 10.1038/nm1195-1162 / Nature Med / Gene transfer through the blood– nerve barrier: NGF-engineered neuritogenic T lymphocytes attenuate experimental autoimmune neuritis by Kramer (1995)
  26. 10.1016/0165-5728(94)00143-C / J Neuroimmunol / Sequence of 104– 117 of myelin proteolipid protein is a cryptic encephalitogenic T cell determinant for SJL/J mice by Tuohy (1995)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 12:49 p.m.)
Deposited 2 years, 1 month ago (July 29, 2023, 11:18 a.m.)
Indexed 1 month ago (Aug. 2, 2025, 12:31 a.m.)
Issued 28 years, 1 month ago (July 7, 1997)
Published 28 years, 1 month ago (July 7, 1997)
Published Online 28 years, 1 month ago (July 7, 1997)
Published Print 28 years, 1 month ago (July 7, 1997)
Funders 0

None

@article{Mathisen_1997, title={Treatment of Experimental Autoimmune Encephalomyelitis with Genetically Modified Memory T Cells}, volume={186}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.186.1.159}, DOI={10.1084/jem.186.1.159}, number={1}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Mathisen, Peter M. and Yu, Min and Johnson, Justin M. and Drazba, Judith A. and Tuohy, Vincent K.}, year={1997}, month=jul, pages={159–164} }